【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 15
2 Introduction 18
2.1 Report Scope 18
2.2 Upcoming Related Reports 19
2.3 Recently Published Reports 19
3 US Private Equity and Venture Capital Industry Dynamics 21
3.1 Post-2008 Financial Market Crash: Volume of Capital Commitments to Private Equity Funds Show Signs of Recovery 21
3.1.1 Venture Capital Fundraising Trend in the US 22
3.2 Volume over Value: Decrease in the Average Value of Completed Private Equity Healthcare Deals between 2007 and 2013 24
3.3 Healthcare Reform and Cost Pressures in Europe and North America Shifts Deal Activity to the Asia-Pacific Region 25
3.4 Private Equity Deals by Therapy Area 28
3.4.1 Central Nervous System, Immunology, Infectious Disease, Metabolic Disorders, and Oncology Enjoying Significant Investment 28
3.5 Private Equity Buyouts of 2013 30
3.6 Venture Capital Investment Trend 31
3.7 Venture Capital Investment: Biotechnology Plays Second Fiddle to Software 34
3.8 Seed-Stage Financing Shows Downward Trend 37
3.9 Venture-Backed Exits in 2013 38
3.9.1 Significant Venture-Backed Biotechnology Acquisitions in 2013 40
3.9.2 Venture-Backed Mergers and Acquisition Witness Strong End to 2013 40
3.10 California, Massachusetts, and New York Lead the Pack in Venture Capital Investment for 2013 42
4 Equity Offerings 44
4.1 Equity Offerings in the Healthcare Sector 44
4.2 Venture-Backed Initial Public Offerings in 2013 45
4.3 Venture-Backed Emerging Biotech Initial Public Offerings in 2013 46
4.4 Liquidity Position Makes Emerging Biotechs an Attractive Prospect for Investors 47
4.5 Company Profiles and Initial Public Offer Details 49
4.5.1 Intrexon Corporation (Stock Symbol: XON) 49
4.5.2 Ophthotech Corporation (Stock Symbol: OPHT) 51
4.5.3 PTC Therapeutics (Stock Symbol: PTCT) 52
4.5.4 Portola Pharmaceuticals (Stock Symbol: PTLA) 54
4.5.5 Agios Pharmaceuticals (Stock Symbol: AGIO) 55
4.5.6 Chimerix (Stock Symbol: CMRX) 57
4.5.7 Bluebird Bio (Stock Symbol: BLUE) 58
4.5.8 Foundation Medicine (Stock Symbol: FMI) 59
4.5.9 OncoMed Pharmaceuticals (Stock Symbol: OMED) 60
4.5.10 Acceleron Pharma (Stock Symbol: XLRN) 62
4.5.11 Prosensa Therapeutics (Stock Symbol: RNA) 64
4.5.12 Epizyme (Stock Symbol: EPZM) 65
4.5.13 Onconova Therapeutics (Stock Symbol: ONTX) 66
4.5.14 Tetraphase Pharmaceuticals (Stock Symbol: TTPH) 68
4.5.15 Esperion Therapeutics (Stock Symbol: ESPR) 69
5 Private Equity Firms: Company Drill-Downs 71
5.1 Section Overview 71
5.2 TPG Capital 72
5.2.1 Overview and Portfolio Management 72
5.2.2 Historical Deals Trend 74
5.2.3 Healthcare-Related Deals in 2013 76
5.3 The Carlyle Group 76
5.3.1 Overview and Portfolio Management 76
5.3.2 Historical Deals Trend 78
5.3.3 Healthcare-Related Deals in 2013 79
5.4 The Blackstone Group 80
5.4.1 Overview and Portfolio Management 80
5.4.2 Historical Deals Trend 82
5.4.3 Healthcare-Related Deals in 2013 83
5.5 Kohlberg Kravis Roberts 83
5.5.1 Overview and Portfolio Management 83
5.5.2 Historical Deals Trend 86
5.5.3 Healthcare-Related Deals in 2013 88
5.6 Warburg Pincus 89
5.6.1 Overview and Portfolio Management 89
5.6.2 Historical Deals Trend 90
5.6.3 Healthcare-Related Deals in 2013 92
5.7 Goldman Sachs Principal Investment Area 93
5.7.1 Overview and Portfolio Management 93
5.7.2 Historical Deals Trend 93
5.8 Advent International Corporation 95
5.8.1 Overview and Portfolio Management 95
5.8.2 Historical Deals Trend 96
5.8.3 Healthcare-Related Deals in 2013 98
5.9 Apollo Global Management 99
5.9.1 Overview and Portfolio Management 99
5.9.2 Healthcare-Related Deals in 2013 99
5.10 Bain Capital 99
5.10.1 Overview and Portfolio Management 99
5.10.2 Historical Deals Trend 100
5.10.3 Healthcare-Related Deals in 2013 101
5.11 CVC Capital Partners 101
5.11.1 Overview and Portfolio Management 101
5.11.2 Historical Deals Trend 102
5.12 Oaktree Capital Management 103
5.12.1 Overview and Portfolio Management 103
5.12.2 Historical Deals Trend 104
5.13 Hellman & Friedman 105
5.13.1 Overview and Portfolio Management 105
5.13.2 Historical Deals Trend 106
6 Venture Capital Firms: Company Drill-Downs 108
6.1 Section Overview 108
6.2 New Enterprise Associates 109
6.2.1 Overview and Portfolio Management 109
6.2.2 Historical Deals Trend 112
6.2.3 Biotechnology Exits and Initial Public Offerings in 2013 114
6.3 OrbiMed Advisors 115
6.3.1 Overview and Portfolio Management 115
6.3.2 Historical Deals Trend 117
6.3.3 Biotechnology Exits and Initial Public Offerings in 2013 119
6.4 Canaan Partners 120
6.4.1 Overview and Portfolio Management 120
6.4.2 Historical Deals Trend 122
6.4.3 Biotechnology Exits and Initial Public Offerings in 2013 123
6.5 Versant Ventures 123
6.5.1 Overview and Portfolio Management 123
6.5.2 Historical Deals Trend 125
6.5.3 Biotechnology Exits and Initial Public Offerings in 2013 127
6.6 New Leaf Venture Partners 128
6.6.1 Overview and Portfolio Management 128
6.6.2 Historical Deals Trend 129
6.6.3 Biotechnology Exits and Initial Public Offerings in 2013 131
6.7 Third Rock Ventures 132
6.7.1 Overview and Portfolio Management 132
6.7.2 Historical Deals Trend 134
6.7.3 Biotechnology Exits and Initial Public Offerings in 2013 136
6.8 Domain Associates 137
6.8.1 Overview and Portfolio Management 137
6.8.2 Historical Deals Trend 139
6.8.3 Biotechnology Exits and Initial Public Offerings in 2013 141
6.9 Kleiner Perkins Caufield & Byers 142
6.9.1 Overview and Portfolio Management 142
6.9.2 Historical Deals Trend 144
6.9.3 Biotechnology Exits and Initial Public Offerings in 2013 146
6.10 Clarus Ventures 147
6.10.1 Overview and Portfolio Management 147
6.10.2 Historical Deals Trend 148
6.10.3 Biotechnology Exits and Initial Public Offerings in 2013 150
6.11 Flagship Ventures 151
6.11.1 Overview and Portfolio Management 151
6.11.2 Historical Deals Trend 153
6.11.3 Biotechnology Exits and Initial Public Offerings in 2013 155
6.12 Additional Venture Capital Firms with Significant Biotechnology Investments 156
6.12.1 Novo A/S 156
6.12.2 InterWest Partners 158
6.12.3 Essex Woodlands Health Ventures 160
6.12.4 Alta Partners 162
6.12.5 Third Security 164
7 Strategic Outlook 166
7.1 New Financing Models Needed for Sustainable Growth of Emerging Biotechs 166
7.2 Aggressive Growth Will Continue in the Asia-Pacific Region 167
7.3 Small and Midsize Funds Will Enjoy Significant Deal Activity 167
7.4 Initial Public Offering Activity Will Increase in 2014 168
7.5 Increased Pressure on Venture Capital Firms 168
8 Appendix 169
8.1 Bibliography 169
8.2 Abbreviations 174
8.3 Research Methodology 178
8.3.1 Coverage 178
8.3.2 Secondary Research 178
8.3.3 Expert Panel Validation 179
8.4 About the Authors 180
8.4.1 Analyst 180
8.4.2 Director of Healthcare Industry Dynamics 180
8.4.3 Global Head of Healthcare 181
8.5 About the Industry Dynamics Team 181
8.6 About GlobalData 182
8.7 Disclosure Information 182
8.8 Disclaimer 182
【レポート販売概要】
■ タイトル：バイオ技術投資レポート：プライベート・エクイティ及びベンチャーキャピタル投資動向■ 英文：PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding
■ 発行日：2014年3月12日
■ 調査会社：GlobalData
■ 商品コード：GDHC005PSR
■ 調査対象地域：グローバル
- 店舗内販売及びショッパーエンゲイジメント改善、ショールーミング対応のモバイルソリューション（Wireless Solutions to Improve In-store Sales, Optimize Shopper Engagement, and Combat "Showrooming"）The retail industry is speedily evolving with spectacular changes in consumer buying behavior. Retailers need to have new strategies to satisfy their customers and enrich their buying experience. Online shopping is getting popular day by day and it is more popular than ever, but brick-and-mortar stores still dominate and have a larger share of the pie. Retailers are now thinking that they need to …
- Google Update Winter 2010The Google Update report provides timely analysis and projections about Google market prospects, products and applications, product and company integration, current and potential mergers and acquisitions, and more. Google Update is available separately and is also part of the subscription service: Google Watch Target Audience Competitors to Google: Any company that either already has or is contemp …
- 世界のソフトウェアテストサービス（アウトソーシング）市場（2014-2018）About Outsourced Software Testing Services Every business today is predominantly run by IT, and what was once a mere business-enabling function is now a strategic function in many organizations. Currently, organizations are investing heavily in IT infrastructure, so the importance of and demand for quality software is growing by the day. It is the quality of the software that differentiates an org …
- 2014年戦略提言：ヨーロッパの呼吸器病診断検査市場Complete report $8,300. DataPack (test volumes, sales forecasts, supplier shares) $5,400.This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this ReportThis report pr …
- 世界のゲノミクス市場（2014-2018）About Genomics Genomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic solutions for a range of human diseases or health conditions. Genomics is supported by three major product segments: Instruments, Consumables, and Services. The key end-users of such products include the Diagnost …
- 特殊テープの世界市場予測（～2024年）Growth in demand for specialty tapes in the healthcare & hygiene application is driving the market. The specialty tapes market size is projected to grow from USD 44.2 billion in 2019 to USD 59.3 billion by 2024, at a CAGR of 6.1% during the forecast period. The growth of the market is primarily due to the increasing use of specialty tapes in the healthcare & hygiene industry. The specialty tapes m …
- 多発性硬化症（MS）の疫学的予測（～2024）EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2024 Summary Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. The course of MS seems to be unpredictable as some people diagnosed with the condition appear to be normal and healthy for …
- DRM市場予測（～2017年）（Digital Rights Management Market Forecast to 2017）Digital Rights Management (DRM) has emerged as the powerful tool to protect the digital content usage. The global market for DRM has witnessed significant changes with a plethora of opportunities in the form of media and entertainment DRM, enterprise DRM, and software DRM. According to our latest research report, “Digital Rights Management Market Forecast to 2017”, the market of DRM is estimated t …
- 世界のバッテリー制御技術市場動向（2012-2016）TechNavio's analysts forecast the Global Battery Control Technology market to grow at a CAGR of 7.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing application of battery control technology in various industries. The Global Battery Control Technology market has also been witnessing the use of battery control technology to increase the …
- 導電性シリコーンの世界市場：エラストマー、樹脂、ゲルThe global conductive silicon market size, in terms of value, is projected to reach USD 4.46 Billion by 2021, at a CAGR of 7.2% between 2016 and 2021. In terms of volume, the market is projected to reach 385.8 kilotons by 2021, at a CAGR of 6.1% during the forecast period. The high demand for electronic components in power generation & distribution and LED industry, increasing silicone demand per …
- 皮革製品の世界市場：革製フットウェア、革製バッグ・財布、革製旅行用かばん、革製アクセサリーAbout Global Leather Goods MarketThe global leather goods market has been registering positive growth over the last few years and is shaping up to become one of the top competitive markets at a global level. With the rise in globalization, ample growth opportunities are being created in the market. Technavio’s analysts forecast the global leather goods market to grow at a CAGR of 4.37% during the …
- サファイアガラスの世界市場ABSTRACTAbout Sapphire Glass Sapphire glass or synthetic sapphire is the purest form of aluminum oxide, also known as alpha-alumina. It is thermally stable, chemically inert, and hard till 2,912°F and has a melting temperature of 3,722°F. It is industrially manufactured from high-purity alumina (HPA) (>99.99% purity). The raw material is fused and processed to produce a hard, polycrystalline produ …
- SECaaS（セキュリティ・サービス）の世界市場予測（～2020）MarketsandMarkets forecasts the Security as a service market size to grow from USD 3.12 Billion in 2015 to USD 8.52 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.2%. The increasing cloud adoption among the enterprises, to reduce cost and increase operational efficiency, has created demand for cloud security. The major factors contributing to the growth of the SECaaS market are inc …
- 世界の政府部門におけるスマートカード市場（2014-2018）About Smart Cards Smart cards are used across various end-user segments for a variety of applications. Smart cards are used extensively for a range of purposes, from basic identification to border security management. Government e-ID cards are cards issued by national governments which give every national a way to prove their identity and residence in their respective country. Various governments …
- 世界主要国における結核検査市場2015The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
